3393 Total Publications
A potential endophenotype for Alzheimer’s disease: cerebrospinal fluid clusterin
Y. Deming, J. Xia, Y. Cai, J. Lord, P. Holmans, S. Bertelsen, D. Holtzman, J. C. Morris, K. Bales, E. H. Pickering, J. Kauwe, A. Goate, C. Cruchaga and I. Alzheimer's Disease Neuroimaging
PMID: 26545630
;
PMCID:5118651
; 2015; Journal Neurobiol Aging; vol. 37; pp. 208 e1-208 e9;
doi:10.1016/j.neurobiolaging.2015.09.009
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients
Brendel, M., Pogarell, O., Xiong, G., Delker, A., Bartenstein, P., & Rominger, A.
PMID: 25631614
;
PMCID:5849231
; 2015; Journal European Journal of Nuclear Medicine and Molecular Imaging; vol. 42; no. 5; pp. 716-24;
doi:10.1007/s00259-014-2975-4
Alzheimer's disease biomarkers as outcome measures for clinical trials in MCI
Caroli, A., Prestia, A., Wade, S., Kewei, C., Ayutyanont, N., Landau, S., … Initiative, for the A. D. N.
PMID: 25437302
;
PMCID:4437812
; 2015; Journal Alzheimer's Disease and Associated Disorders; vol. 29; no. 2; pp. 101-109;
doi:10.1097/WAD.0000000000000071
Improved Power for Characterizing Longitudinal Amyloid-b PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region
Chen K1, Roontiva A2, Thiyyagura P2, Lee W2, Liu X2, Ayutyanont N2, Protas H2, Luo JL2, Bauer R2, Reschke C2, Bandy D2, Koeppe RA3, Fleisher AS4, Caselli RJ5, Landau S6, Jagust WJ6, Weiner MW7, Reiman EM8; Alzheimer’s Disease Neuroimaging Initiative.
PMID: 25745091
; 2015; Journal J Nucl Med; vol. 56; no. 4; pp. 560-6;
doi:10.2967/jnumed.114.149732